Midland Wealth Advisors LLC Has $208,000 Stock Holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Midland Wealth Advisors LLC cut its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 8.7% in the 1st quarter, Holdings Channel.com reports. The fund owned 419 shares of the medical equipment provider’s stock after selling 40 shares during the quarter. Midland Wealth Advisors LLC’s holdings in Intuitive Surgical were worth $208,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in ISRG. Norges Bank acquired a new position in Intuitive Surgical in the 4th quarter valued at $2,401,493,000. GAMMA Investing LLC raised its holdings in Intuitive Surgical by 54,010.7% in the 1st quarter. GAMMA Investing LLC now owns 3,028,576 shares of the medical equipment provider’s stock valued at $14,999,630,000 after acquiring an additional 3,022,979 shares in the last quarter. Proficio Capital Partners LLC raised its holdings in Intuitive Surgical by 89,098.8% in the 4th quarter. Proficio Capital Partners LLC now owns 949,967 shares of the medical equipment provider’s stock valued at $495,845,000 after acquiring an additional 948,902 shares in the last quarter. Capital Research Global Investors raised its holdings in Intuitive Surgical by 25.5% in the 4th quarter. Capital Research Global Investors now owns 3,381,302 shares of the medical equipment provider’s stock valued at $1,764,904,000 after acquiring an additional 687,906 shares in the last quarter. Finally, Raymond James Financial Inc. acquired a new position in Intuitive Surgical in the 4th quarter valued at $313,769,000. 83.64% of the stock is owned by institutional investors and hedge funds.

Insider Activity at Intuitive Surgical

In related news, EVP Gary Loeb sold 1,700 shares of the company’s stock in a transaction dated Friday, April 25th. The stock was sold at an average price of $513.18, for a total transaction of $872,406.00. Following the sale, the executive vice president now owns 2,245 shares in the company, valued at $1,152,089.10. This represents a 43.09% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, EVP Robert Desantis sold 11,545 shares of the company’s stock in a transaction dated Thursday, March 13th. The shares were sold at an average price of $499.22, for a total value of $5,763,494.90. Following the sale, the executive vice president now owns 5,224 shares in the company, valued at approximately $2,607,925.28. The trade was a 68.85% decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 16,543 shares of company stock worth $8,375,072 in the last 90 days. Corporate insiders own 0.70% of the company’s stock.

Intuitive Surgical Trading Down 5.6%

NASDAQ ISRG opened at $526.15 on Tuesday. The business’s 50-day moving average price is $522.38 and its two-hundred day moving average price is $539.01. Intuitive Surgical, Inc. has a 12 month low of $413.52 and a 12 month high of $616.00. The firm has a market capitalization of $188.58 billion, a PE ratio of 82.08, a price-to-earnings-growth ratio of 5.85 and a beta of 1.67.

Intuitive Surgical (NASDAQ:ISRG) last released its quarterly earnings results on Tuesday, April 22nd. The medical equipment provider reported $1.81 EPS for the quarter, beating analysts’ consensus estimates of $1.71 by $0.10. Intuitive Surgical had a return on equity of 14.55% and a net margin of 27.81%. The firm had revenue of $2.25 billion for the quarter, compared to analyst estimates of $2.19 billion. During the same quarter in the previous year, the company posted $1.50 EPS. As a group, analysts forecast that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

Several equities analysts have weighed in on ISRG shares. Royal Bank of Canada dropped their price objective on Intuitive Surgical from $630.00 to $605.00 and set an “outperform” rating for the company in a report on Wednesday, April 23rd. Barclays lowered their price target on Intuitive Surgical from $684.00 to $635.00 and set an “overweight” rating for the company in a report on Thursday, April 24th. Robert W. Baird lowered their price target on Intuitive Surgical from $600.00 to $575.00 and set an “outperform” rating for the company in a report on Wednesday, April 23rd. Truist Financial lowered their price target on Intuitive Surgical from $605.00 to $590.00 and set a “buy” rating for the company in a report on Wednesday, April 23rd. Finally, Citigroup reissued a “buy” rating and set a $650.00 price target (up previously from $590.00) on shares of Intuitive Surgical in a report on Thursday, May 22nd. One equities research analyst has rated the stock with a sell rating, four have assigned a hold rating and fifteen have issued a buy rating to the stock. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $588.95.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.